BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36822081)

  • 1. Retraction notice to "Downregulation of microRNA-21-5p from macrophages-derived exosomes represses ventricular remodeling after myocardial infarction via inhibiting tissue inhibitors of metalloproteinase 3" [Int. Immunopharmacol. 96 (2021) 107611].
    Dong J; Zhu W; Wan D
    Int Immunopharmacol; 2023 Apr; 117():109862. PubMed ID: 36822081
    [No Abstract]   [Full Text] [Related]  

  • 2. Retraction notice to "BMSCs-derived exosomal microRNA-150-5p attenuates myocardial infarction in mice" [Int. Immunopharmacol. 93 (2021) 107389].
    Wu Z; Cheng S; Wang S; Li W; Liu J
    Int Immunopharmacol; 2023 Apr; 117():109863. PubMed ID: 36822088
    [No Abstract]   [Full Text] [Related]  

  • 3. Retraction notice to "Human bone mesenchymal stem cells-derived exosomes overexpressing microRNA-26a-5p alleviate osteoarthritis via down-regulation of PTGS2" [Int. Immunopharmacol. 78 (2020) 105946].
    Jin Z; Ren J; Qi S
    Int Immunopharmacol; 2023 Apr; 117():109943. PubMed ID: 36914435
    [No Abstract]   [Full Text] [Related]  

  • 4. Retraction notice to "Upregulated microRNA-381-5p strengthens the effect of dexmedetomidinepreconditioning to protect against myocardial ischemia-reperfusion injuryin mouse models by inhibiting CHI3L1" [Int. Immunopharmacol. 92 (2021) 107326].
    Deng Y; Cai L; Wang F; Huang J; Wang H; Li L; Lv H
    Int Immunopharmacol; 2023 Apr; 117():109864. PubMed ID: 36822095
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to "Bone marrow mesenchymal stem cells-derived exosomal microRNA-185represses ventricular remolding of mice with myocardial infarction byinhibiting SOCS2" [Int. Immunopharmacol. 80 (2020) 106156].
    Li Y; Zhou J; Zhang O; Wu X; Guan X; Xue Y; Li S; Zhuang X; Zhou B; Miao G; Zhang L
    Int Immunopharmacol; 2023 Apr; 117():109871. PubMed ID: 36822089
    [No Abstract]   [Full Text] [Related]  

  • 6. Retraction notice to "MicroRNA-208-5p regulates myocardial injury of sepsis mice via targeting SOCS2-mediated NF-κB/HIF-1a pathway" [Int. Immunopharmacol. 81 (2020) 106204].
    Ouyang H; Tan Y; Li Q; Xia F; Xiao X; Zheng S; Lu J; Zhong J; Hu Y
    Int Immunopharmacol; 2023 Apr; 117():109870. PubMed ID: 36822086
    [No Abstract]   [Full Text] [Related]  

  • 7. Retraction notice to "Bone marrow-derived mesenchymal stem cells-secreted exosomal microRNA-192-5p delays inflammatory response in rheumatoid arthritis" [Int. Immunopharmacol. 78 (2020) 105985].
    Zheng J; Zhu L; In II; Chen Y; Jia N; Zhu W
    Int Immunopharmacol; 2023 Mar; 116():109873. PubMed ID: 36858851
    [No Abstract]   [Full Text] [Related]  

  • 8. Retraction notice to "Down-regulated microRNA-195-5p and up-regulated CXCR4 attenuates the heart function injury of heart failure mice via inactivating JAK/STAT pathway" [Int. Immunopharmacol. 82 (2020) 106225].
    Shen Y; Zhang W; Lee L; Hong M; Lee M; Chou G; Yu L; Sui Y; Chou B
    Int Immunopharmacol; 2023 Apr; 117():109868. PubMed ID: 36822100
    [No Abstract]   [Full Text] [Related]  

  • 9. Retraction notice to "MicroRNA-375-3p in endothelial progenitor cells-derived extracellular vesicles relieves myocardial injury in septic rats via BRD4-mediated PI3K/AKT signaling pathway" [Int. Immunopharmacol. 96 (2021) 107740].
    Hong X; Wang J; Li S; Zhao Z; Feng Z
    Int Immunopharmacol; 2023 Apr; 117():109857. PubMed ID: 36822097
    [No Abstract]   [Full Text] [Related]  

  • 10. Retraction notice to "Exosomal microRNA-16-5p from adipose mesenchymal stem cells promotes TLR4-mediated M2 macrophage polarization in septic lung injury" [Int. Immunopharmacol. 98 (2021) 107835].
    Tian J; Cui X; Sun J; Zhang J
    Int Immunopharmacol; 2022 Oct; 111():109078. PubMed ID: 35952514
    [No Abstract]   [Full Text] [Related]  

  • 11. Retraction notice to "Inhibition of interleukin-1β plays a protective role in Alzheimer's disease by promoting microRNA-9-5p and downregulating targeting protein for xenopus kinesin-like protein 2" [Int. Immunopharmacol. 97 (2021) 107578].
    Zhang YY; Dong LX; Bao HL; Liu Y; An FM; Zhang GW
    Int Immunopharmacol; 2023 Apr; 117():109856. PubMed ID: 36822082
    [No Abstract]   [Full Text] [Related]  

  • 12. Exosomes derived from miR-129-5p modified bone marrow mesenchymal stem cells represses ventricular remolding of mice with myocardial infarction.
    Wang S; Dong J; Li L; Wu R; Xu L; Ren Y; Hu X
    J Tissue Eng Regen Med; 2022 Feb; 16(2):177-187. PubMed ID: 34814233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retraction notice to "LncRNA NEAT1 inhibition upregulates miR-16-5p to restrain the progression of sepsis-induced lung injury via suppressing BRD4 in amouse model" [Int. Immunopharmacol. 97 (2021) 107691].
    Yin J; Han B; Shen Y
    Int Immunopharmacol; 2023 Apr; 117():109855. PubMed ID: 36822093
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of Cardiomyocyte-Derived Exosomal MicroRNA-146a-5p in Macrophage Polarization and Activation.
    Chen C; Cai S; Wu M; Wang R; Liu M; Cao G; Dong M; Yiu KH
    Dis Markers; 2022; 2022():2948578. PubMed ID: 35548775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retraction notice to "Long non-coding RNA Mirt2 prevents TNF-α-triggered inflammation via the repression of microRNA-101" [Int. Immunopharmacol. 76 (2019) 105878].
    Han Y; Kang C; Kang M; Quan W; Gao H; Zhong Z
    Int Immunopharmacol; 2021 Oct; 99():108030. PubMed ID: 34353735
    [No Abstract]   [Full Text] [Related]  

  • 16. Retraction notice to "Corrigendum to "MLL1 promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis by activating the TRIF/NF-κB signaling pathway via H3K4me3 enrichment in the TLR4 promoter region"" [Int. Immunopharmacol. 82 (2020) 106220] [Int. Immunopharmacol. 92 (2021) 107321].
    Zhang Y; Ji T; Ma S; Wu W
    Int Immunopharmacol; 2023 Apr; 117():109865. PubMed ID: 36822094
    [No Abstract]   [Full Text] [Related]  

  • 17. Retraction notice to "MicroRNA-204-GSDMD interaction regulates pyroptosis of fibroblast-like synoviocytes in ankylosing spondylitis" [Int. Immunopharmacol. 91 (2020) 107227].
    Gu G; Huo Y; Xu G; Li L; Yu J; Sheng L; Yin Z
    Int Immunopharmacol; 2023 Apr; 117():109866. PubMed ID: 36822091
    [No Abstract]   [Full Text] [Related]  

  • 18. Retraction notice to "Salidroside protects ATDC5 cells against lipopolysaccharide-induced injury through up-regulation of microRNA-145 in osteoarthritis" [Int. Immunopharmacol. 67 (2019) 441-448].
    Liu M; Zhang J; Liu W; Wang W
    Int Immunopharmacol; 2021 Jun; 95():107711. PubMed ID: 33933373
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma exosomes from patients with acute myocardial infarction alleviate myocardial injury by inhibiting ferroptosis through miR-26b-5p/SLC7A11 axis.
    Li H; Ding J; Liu W; Wang X; Feng Y; Guan H; Chen Z
    Life Sci; 2023 Jun; 322():121649. PubMed ID: 37011873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retraction notice to "The protective role of microRNA-133b in restricting hippocampal neurons apoptosis and inflammatory injury in rats with depression by suppressing CTGF" [Int. Immunopharmacol. 78 (2020) 106076].
    Pei G; Xu L; Huang W; Yin J
    Int Immunopharmacol; 2023 Apr; 117():109872. PubMed ID: 36822080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.